Procept Biorobotics (PRCT)

• Market cap: $2.19B
• 1 day: -4.66%
• 5 days: -3.65%
• 1 month: -29.45%
• 3 months: -32.84%
• 6 months: -37.31%
• Year to date: -52.73%
• 1 year: -49.62%
• 5 years: -6.27%
• 10 years: -6.27%
• Sector: Healthcare
• Industry: Medical Devices

About: PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Employees: 756

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

48% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 81

21% more call options, than puts

Call options by funds: $7.9M | Put options by funds: $6.55M

4.23% more ownership

Funds ownership: 92.01% [Q1] → 96.24% (+4.23%) [Q2]

4% more capital invested

Capital invested by funds: $2.94B [Q1] → $3.07B (+$128M) [Q2]

5% less funds holding

Funds holding: 278 [Q1] → 264 (-14) [Q2]

22% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 41

44% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 5 (-4) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $55 40% upside
• Avg. target: $60 53% upside
• High target: $68 73% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Wells Fargo Nathan Treybeck	48% upside $58	Overweight Maintained	7 Aug 2025
Piper Sandler Matt O'Brien	40% upside $55	Overweight Maintained	7 Aug 2025
Morgan Stanley Patrick Wood	73% upside $68	Overweight Maintained	15 Jul 2025